A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men
Conditions
- Drug-Drug Interaction (DDI)
- Healthy Subjects
- Pharmacokinetics of Enzalutamide
Interventions
- DRUG: enzalutamide
- DRUG: rifampin
Sponsor
Astellas Pharma Europe B.V.
Collaborators